KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Net Margin (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Net Margin data on record, last reported at 6.15% in Q4 2025.

  • For Q4 2025, Net Margin rose 3307.0% year-over-year to 6.15%; the TTM value through Dec 2025 reached 8.57%, up 700.0%, while the annual FY2025 figure was 8.57%, 700.0% up from the prior year.
  • Net Margin reached 6.15% in Q4 2025 per ZBH's latest filing, down from 11.55% in the prior quarter.
  • Across five years, Net Margin topped out at 13.66% in Q3 2024 and bottomed at 30.44% in Q4 2023.
  • Average Net Margin over 5 years is 4.26%, with a median of 8.89% recorded in 2022.
  • The widest YoY moves for Net Margin: up 4059bps in 2021, down -4156bps in 2021.
  • A 5-year view of Net Margin shows it stood at 1.64% in 2021, then skyrocketed by 626bps to 8.64% in 2022, then tumbled by -452bps to 30.44% in 2023, then grew by 12bps to 26.92% in 2024, then skyrocketed by 123bps to 6.15% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 6.15% in Q4 2025, 11.55% in Q3 2025, and 7.38% in Q2 2025.